Safety, tolerability and immunogenicity of the ExPEC4V (JNJ-63871860) vaccine for prevention of invasive extraintestinal pathogenic Escherichia coli disease: A phase 1, randomized, double-blind, placebo-controlled study in healthy Japanese participants

Population structure of Japanese extraintestinal pathogenicEscherichia coliand its relationship with antimicrobial resistance

(2017) Yasufumi Matsumura et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial

(2017) Angela Huttner et al.   LANCET INFECTIOUS DISEASES

Immunogenicity and safety of a tetravalent E. coli O-antigen bioconjugate vaccine in animal models

(2016) Germie P.J.M. van den Dobbelsteen et al.   VACCINE

Extraintestinal PathogenicEscherichia coli, a Common Human Pathogen: Challenges for Vaccine Development and Progress in the Field

(2015) Jan T. Poolman et al.   JOURNAL OF INFECTIOUS DISEASES

Escherichia coli bacteraemia in adults: age-related differences in clinical and bacteriological characteristics, and outcome

(2014) C. ROUBAUD BAUDRON et al.   EPIDEMIOLOGY AND INFECTION

Human and Avian Extraintestinal Pathogenic Escherichia coli: Infections, Zoonotic Risks, and Antibiotic Resistance Trends

(2013) Melha Mellata   Foodborne Pathogens and Disease

Extraintestinal Pathogenic Escherichia coli: A Combination of Virulence with Antibiotic Resistance

(2012) Johann D. D. Pitout   Frontiers in Microbiology

Clonal spread in Eastern Asia of ciprofloxacin-resistant Escherichia coli serogroup O25 strains, and associated virulence factors

(2010) Yujiro Uchida et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Change in the prevalence of extended-spectrum- -lactamase-producing Escherichia coli in Japan by clonal spread

(2008) S. Suzuki et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY